Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetic Retinopathy

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

Type I Diabetes III: Clinical Manifestations

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

Complications of Diabetes Mellitus

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Evaluation Of Fibroscan® In The Prediction Of Esophageal Varices In Cirrhotic Patients Followed At Cocody'shospital].

Le Mali medical·2024

Same author

[Internal Hemorroïd Disease In Digestive Endoscopy Center Of Chu Gabriel Toure Of Bamako].

Le Mali medical·2024

Same author

[Role Of Imaging In The Management Of A Case Of Intrauterine Device Migration].

Le Mali medical·2024

Same author

[Cerebral toxoplasmosis in the infectious diseases department of the CHU du Point G in people living with HIV].

Le Mali medical·2024

Same author

[Internal Hemorroïd Disease In Digestive Endoscopy Center Of Chu Gabriel Toure Of Bamako].

Le Mali medical·2024

Same author

[Stroke in type 2 diabetic patients in the internal medicine department of the Teaching Hospital of Point G].

Le Mali medical·2024

Same journal

[Factors associated with Covid 19 vaccines Hesitancy in Mali, household survey, 2021].

Le Mali medical·2024

Same journal

[Prevalence Of Mental Disorders And Addictive Behaviours Among Artisanal Gold Miners In Burkina Faso].

Le Mali medical·2024

Same journal

[Factors associated with mortality in patients with COVID-19 in the Tambacounda region, Senegal, 2020-2021].

Le Mali medical·2024

Same journal

[Factors Associated With Neonatal Mortality In Diamare, Cameroon].

Le Mali medical·2024

Same journal

[Giant Ossifiant Fibrome Of The Mandibule In The Adolescent At The National Center D'odonto-Stomatologie Of Bamako].

Le Mali medical·2024

Same journal

[Post-Vaccination Adverse Events Related To The Administration Of The Covishield® Coronavirus Vaccine In Vaccinated Volunteers At The Bamako Dermatology Hospital From April To June 2021].

Le Mali medical·2024

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

[The diabetic hand].

A T Sidibe¹, M Dembele, I A Cisse

¹Service de Médecine interne, Hôpital National du Point G, Bamako, Mali.

Le Mali Medical

|May 14, 2009

Summary

This summary is machine-generated.

Diabetic hand infections are common, affecting 16.13% of patients, often without a clear entry point. These infections can lead to severe complications, including amputation, highlighting the need for increased awareness and management strategies.

More Related Videos

Fat-Covered Islet Transplantation Using Epididymal White Adipose Tissue

Fat-Covered Islet Transplantation Using Epididymal White Adipose Tissue

Published on: May 25, 2021

Related Experiment Videos

Last Updated: Jun 23, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

Fat-Covered Islet Transplantation Using Epididymal White Adipose Tissue

Fat-Covered Islet Transplantation Using Epididymal White Adipose Tissue

Published on: May 25, 2021

Area of Science:

Infectious Diseases
Endocrinology
Public Health

Context:

Diabetes mellitus significantly increases susceptibility to infections.
Infections in diabetic patients often present atypically, deviating from classic descriptions like diabetic foot.
Limited data exists on the prevalence and characteristics of diabetic hand infections.

Purpose:

To determine the prevalence of "diabetic hand" infections.
To describe the clinical presentation and outcomes of diabetic hand infections.
To identify risk factors and common pathogens associated with diabetic hand infections.

Summary:

A study of 341 diabetic patients found soft tissue infections in 46.33%, with 16.13% localized to the hand.
Hand infections were more common in females, averaging 52 years old, with recent diabetes diagnoses (Type I and II).
Abscesses (49.09%), whitlow (25.46%), and gangrene (21.82%) were common, with osteitis in 41.81%; Staphylococcus was the predominant pathogen.

Impact:

Diabetic hand infections frequently require aggressive treatment, including amputation in 30.9% of cases.
While 76.3% achieved healing, significant functional sequelae were noted.
A mortality rate of 9.09% underscores the severity of these infections in diabetic patients.